Dose-Dependent Bioavailability and CYP3A Inhibition Contribute to Non-Linear Pharmacokinetics of Voriconazole

2016 ◽  
Vol 55 (12) ◽  
pp. 1535-1545 ◽  
Author(s):  
Nicolas Hohmann ◽  
Franziska Kocheise ◽  
Alexandra Carls ◽  
Jürgen Burhenne ◽  
Johanna Weiss ◽  
...  
2020 ◽  
Author(s):  
Yh. Taguchi ◽  
Turki Turki

ABSTRACTThe accurate prediction of new interactions between drugs is important for avoiding unknown (mild or severe) adverse reactions to drug combinations. The development of effective in silico methods for evaluating drug interactions based on gene expression data requires an under-standing of how various drugs alter gene expression. Current computational methods for the prediction of drug-drug interactions (DDIs) utilize data for known DDIs to predict unknown interactions. However, these methods are limited in the absence of known predictive DDIs. To improve DDIs’ interpretation, a recent study has demonstrated strong non-linear (i.e., dose-dependent) effects of DDIs. In this study, we present a new unsupervised learning approach involving tensor decomposition (TD)-based unsupervised feature extraction (FE) in 3D. We utilize our approach to reanalyze available gene expression profiles for Saccharomyces cerevisiae. We found that non-linearity is possible, even for single drugs. Thus, non-linear dose-dependence cannot always be attributed to DDIs. Our analysis provides a basis for the design of effective methods for evaluating DDIs.


1997 ◽  
Vol 44 (3) ◽  
pp. 255-260 ◽  
Author(s):  
G. Toffoli ◽  
I. Robieux ◽  
D. Fantin ◽  
M. Gigante ◽  
S. Frustaci ◽  
...  

2015 ◽  
Vol 55 (1) ◽  
pp. 1-15 ◽  
Author(s):  
Sieto Bosgra ◽  
Maria L. H. Vlaming ◽  
Wouter H. J. Vaes

2016 ◽  
Vol 24 (3) ◽  
pp. 490-493
Author(s):  
Atsunori Sugimoto ◽  
Yutaro Suzuki ◽  
Naoki Orime ◽  
Taketsugu Hayashi ◽  
Jun Egawa ◽  
...  

Objective: The objective was to reveal the relationship between dose and concentration of atomoxetine. Method: Fifty-five blood samples of 33 patients with ADHD were examined using high-performance liquid chromatography. Results: The plasma concentrations were 53.2 ± 67.0, 298.0 ± 390.5, and 639.3 ± 831.9 ng/mL at doses of 40 mg, 80 mg, and 120 mg, and the concentration/dose were 1.33 ± 1.67, 3.73 ± 4.88, and 5.33 ± 6.93 ng/mL/mg, respectively. Statistical analyses revealed a significant correlation between the concentration and the dose of atomoxetine ( p = .004), and a trending toward significance in the difference in the concentration/dose in the three dosage groups ( p = .064). The concentration/dose at 40 and 80 + 120 mg/day were 1.33 ± 1.67 and 4.22 ± 5.53 ng/mL/mg, the latter was significantly higher than the former ( p = .006), which suggested non-linear pharmacokinetics. Conclusion: Clinicians should carefully titrate in high dose atomoxetine treatment.


1988 ◽  
Vol 9 (4) ◽  
pp. 363-376 ◽  
Author(s):  
James J. Ferry ◽  
John G. Wagner

Sign in / Sign up

Export Citation Format

Share Document